| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Penis | 52 | 2018 | 90 | 8.380 |
Why?
|
| Erectile Dysfunction | 20 | 2022 | 39 | 5.710 |
Why?
|
| Penile Induration | 21 | 2018 | 25 | 4.830 |
Why?
|
| Stem Cells | 13 | 2022 | 151 | 3.450 |
Why?
|
| Nitric Oxide Synthase | 27 | 2010 | 134 | 3.090 |
Why?
|
| Phosphodiesterase Inhibitors | 13 | 2012 | 35 | 2.700 |
Why?
|
| Transforming Growth Factor beta | 22 | 2008 | 214 | 2.700 |
Why?
|
| Muscle, Skeletal | 20 | 2013 | 308 | 2.260 |
Why?
|
| Fibrosis | 26 | 2011 | 166 | 2.260 |
Why?
|
| Stem Cell Transplantation | 6 | 2019 | 37 | 2.180 |
Why?
|
| Impotence, Vasculogenic | 7 | 2012 | 13 | 2.000 |
Why?
|
| Penile Erection | 16 | 2017 | 26 | 2.000 |
Why?
|
| Rats | 59 | 2020 | 3701 | 1.980 |
Why?
|
| Dyslipidemias | 3 | 2022 | 48 | 1.890 |
Why?
|
| Diabetes Mellitus, Experimental | 5 | 2018 | 126 | 1.640 |
Why?
|
| Piperazines | 8 | 2012 | 117 | 1.620 |
Why?
|
| Myostatin | 18 | 2017 | 61 | 1.550 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2020 | 744 | 1.540 |
Why?
|
| Sulfones | 8 | 2012 | 47 | 1.460 |
Why?
|
| Rats, Inbred F344 | 26 | 2013 | 256 | 1.430 |
Why?
|
| Animals | 82 | 2020 | 16695 | 1.390 |
Why?
|
| Male | 91 | 2022 | 22779 | 1.250 |
Why?
|
| Muscle, Smooth | 15 | 2018 | 59 | 1.240 |
Why?
|
| Aging | 16 | 2015 | 764 | 1.200 |
Why?
|
| Nitric Oxide Synthase Type II | 16 | 2018 | 128 | 1.170 |
Why?
|
| Myocytes, Smooth Muscle | 6 | 2017 | 92 | 1.120 |
Why?
|
| Transforming Growth Factor beta1 | 9 | 2014 | 97 | 1.120 |
Why?
|
| Gene Expression | 11 | 2017 | 692 | 1.000 |
Why?
|
| Immunohistochemistry | 20 | 2017 | 928 | 0.990 |
Why?
|
| Rats, Zucker | 8 | 2020 | 23 | 0.900 |
Why?
|
| Thiazolidinediones | 3 | 2010 | 49 | 0.880 |
Why?
|
| Ethanol | 2 | 2016 | 221 | 0.850 |
Why?
|
| Benzhydryl Compounds | 2 | 2013 | 49 | 0.810 |
Why?
|
| Cell Differentiation | 12 | 2018 | 633 | 0.790 |
Why?
|
| Phenols | 2 | 2013 | 102 | 0.770 |
Why?
|
| Fibroblasts | 9 | 2009 | 278 | 0.740 |
Why?
|
| Blotting, Western | 16 | 2009 | 884 | 0.730 |
Why?
|
| Muscle Fibers, Skeletal | 4 | 2013 | 70 | 0.720 |
Why?
|
| Apoptosis | 14 | 2020 | 1541 | 0.700 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2020 | 1 | 0.670 |
Why?
|
| Disease Models, Animal | 11 | 2020 | 1554 | 0.670 |
Why?
|
| Palmitic Acid | 1 | 2020 | 23 | 0.660 |
Why?
|
| Kidney Tubules | 2 | 2010 | 38 | 0.620 |
Why?
|
| Urinary Incontinence | 1 | 2019 | 15 | 0.620 |
Why?
|
| Obesity | 3 | 2020 | 1131 | 0.620 |
Why?
|
| Receptors, Androgen | 8 | 2005 | 144 | 0.620 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2017 | 142 | 0.610 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2018 | 6 | 0.590 |
Why?
|
| Testosterone | 9 | 2015 | 211 | 0.590 |
Why?
|
| Cholesterol | 1 | 2020 | 230 | 0.590 |
Why?
|
| Collagen | 7 | 2014 | 178 | 0.570 |
Why?
|
| Oxidative Stress | 9 | 2015 | 990 | 0.560 |
Why?
|
| Vagina | 3 | 2009 | 89 | 0.560 |
Why?
|
| Hypoglycemic Agents | 3 | 2010 | 181 | 0.550 |
Why?
|
| Cells, Cultured | 12 | 2020 | 1617 | 0.520 |
Why?
|
| Carbolines | 2 | 2007 | 17 | 0.520 |
Why?
|
| Muscle Development | 4 | 2013 | 51 | 0.510 |
Why?
|
| Mesoderm | 2 | 2008 | 73 | 0.510 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 71 | 0.500 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 532 | 0.500 |
Why?
|
| RNA, Small Interfering | 3 | 2008 | 436 | 0.500 |
Why?
|
| Mice | 20 | 2013 | 6490 | 0.480 |
Why?
|
| Molsidomine | 2 | 2012 | 4 | 0.480 |
Why?
|
| RNA, Messenger | 17 | 2014 | 1265 | 0.470 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 3 | 2010 | 8 | 0.460 |
Why?
|
| Myoblasts | 4 | 2009 | 30 | 0.460 |
Why?
|
| Gene Transfer Techniques | 2 | 2006 | 53 | 0.460 |
Why?
|
| Arginine | 5 | 2006 | 75 | 0.460 |
Why?
|
| Humans | 47 | 2022 | 42163 | 0.450 |
Why?
|
| Breast | 1 | 2016 | 139 | 0.450 |
Why?
|
| Nitric Oxide | 10 | 2015 | 381 | 0.440 |
Why?
|
| Purines | 6 | 2012 | 40 | 0.440 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2013 | 21 | 0.420 |
Why?
|
| Muscle Proteins | 3 | 2003 | 52 | 0.420 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 11 | 2007 | 649 | 0.410 |
Why?
|
| Endocrine Disruptors | 1 | 2013 | 43 | 0.400 |
Why?
|
| Muscle Denervation | 1 | 2012 | 4 | 0.390 |
Why?
|
| DNA, Complementary | 5 | 2004 | 195 | 0.390 |
Why?
|
| Epithelial Cells | 1 | 2016 | 426 | 0.390 |
Why?
|
| Vasodilator Agents | 1 | 2012 | 55 | 0.380 |
Why?
|
| Nitric Oxide Synthase Type I | 9 | 2013 | 57 | 0.380 |
Why?
|
| Weightlessness | 2 | 2002 | 27 | 0.360 |
Why?
|
| Gene Expression Regulation | 8 | 2016 | 1066 | 0.350 |
Why?
|
| Antifibrinolytic Agents | 1 | 2010 | 4 | 0.340 |
Why?
|
| Multipotent Stem Cells | 2 | 2008 | 16 | 0.340 |
Why?
|
| Adipocytes | 3 | 2005 | 58 | 0.330 |
Why?
|
| Androgens | 4 | 2004 | 107 | 0.330 |
Why?
|
| Prostatectomy | 2 | 2007 | 69 | 0.330 |
Why?
|
| Neovascularization, Physiologic | 1 | 2010 | 80 | 0.330 |
Why?
|
| Myocardium | 1 | 2012 | 251 | 0.320 |
Why?
|
| Cell Line | 7 | 2016 | 1416 | 0.320 |
Why?
|
| Diabetic Nephropathies | 1 | 2010 | 74 | 0.320 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 242 | 0.310 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 2 | 2007 | 7 | 0.310 |
Why?
|
| In Situ Nick-End Labeling | 5 | 2010 | 138 | 0.310 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2009 | 9 | 0.310 |
Why?
|
| Prostate | 3 | 2000 | 152 | 0.310 |
Why?
|
| Tissue Scaffolds | 1 | 2009 | 31 | 0.310 |
Why?
|
| Penile Diseases | 1 | 2009 | 6 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2008 | 1737 | 0.300 |
Why?
|
| Tunica Media | 1 | 2009 | 14 | 0.300 |
Why?
|
| Peripheral Nerves | 1 | 2008 | 14 | 0.300 |
Why?
|
| Imidazoles | 2 | 2006 | 138 | 0.290 |
Why?
|
| Muscular Atrophy | 3 | 2003 | 13 | 0.290 |
Why?
|
| Breast Neoplasms | 2 | 2016 | 1679 | 0.290 |
Why?
|
| Aorta | 1 | 2009 | 197 | 0.280 |
Why?
|
| Antioxidants | 1 | 2011 | 439 | 0.280 |
Why?
|
| Genitalia, Male | 1 | 2007 | 14 | 0.260 |
Why?
|
| PPAR gamma | 1 | 2007 | 55 | 0.260 |
Why?
|
| Sexual Maturation | 3 | 1998 | 24 | 0.260 |
Why?
|
| Pluripotent Stem Cells | 2 | 2003 | 30 | 0.260 |
Why?
|
| Cyclic GMP | 3 | 2018 | 55 | 0.260 |
Why?
|
| Recombinant Proteins | 5 | 2008 | 522 | 0.260 |
Why?
|
| Acetaldehyde | 2 | 2016 | 11 | 0.260 |
Why?
|
| Diabetic Angiopathies | 1 | 2006 | 26 | 0.250 |
Why?
|
| Mice, Knockout | 4 | 2013 | 1010 | 0.250 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2006 | 23 | 0.250 |
Why?
|
| Priapism | 1 | 2006 | 2 | 0.250 |
Why?
|
| Space Flight | 2 | 2002 | 18 | 0.240 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2016 | 1112 | 0.230 |
Why?
|
| Myocytes, Cardiac | 1 | 2007 | 173 | 0.230 |
Why?
|
| Endothelium, Vascular | 3 | 2015 | 261 | 0.230 |
Why?
|
| Electric Stimulation | 4 | 2013 | 198 | 0.220 |
Why?
|
| Enzyme Inhibitors | 5 | 2011 | 457 | 0.220 |
Why?
|
| Dupuytren Contracture | 1 | 2004 | 1 | 0.220 |
Why?
|
| Body Composition | 3 | 2003 | 160 | 0.220 |
Why?
|
| Reproduction | 2 | 2002 | 92 | 0.210 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2003 | 19 | 0.210 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2014 | 310 | 0.210 |
Why?
|
| Base Sequence | 6 | 2006 | 997 | 0.210 |
Why?
|
| Actins | 4 | 2010 | 162 | 0.210 |
Why?
|
| Fibrin | 1 | 2003 | 10 | 0.210 |
Why?
|
| Hypothalamus | 2 | 2001 | 121 | 0.200 |
Why?
|
| Aromatase | 1 | 2003 | 20 | 0.200 |
Why?
|
| Endothelium | 2 | 2016 | 28 | 0.200 |
Why?
|
| Neurons | 3 | 2001 | 1246 | 0.200 |
Why?
|
| Signal Transduction | 8 | 2015 | 2111 | 0.200 |
Why?
|
| Menopause | 1 | 2003 | 63 | 0.200 |
Why?
|
| Female | 10 | 2020 | 24018 | 0.200 |
Why?
|
| Organ Size | 5 | 2007 | 167 | 0.190 |
Why?
|
| Administration, Oral | 3 | 2013 | 256 | 0.190 |
Why?
|
| Myosin Heavy Chains | 1 | 2002 | 18 | 0.190 |
Why?
|
| Transfection | 5 | 2007 | 526 | 0.180 |
Why?
|
| Immediate-Early Proteins | 1 | 2002 | 50 | 0.180 |
Why?
|
| Enzyme Induction | 3 | 2009 | 53 | 0.180 |
Why?
|
| Cell Proliferation | 3 | 2016 | 1420 | 0.180 |
Why?
|
| Tyrosine | 1 | 2001 | 119 | 0.170 |
Why?
|
| Somatomedins | 1 | 2000 | 5 | 0.170 |
Why?
|
| Kidney | 2 | 2009 | 363 | 0.170 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 683 | 0.170 |
Why?
|
| Urinary Bladder | 1 | 2000 | 30 | 0.170 |
Why?
|
| Transcription, Genetic | 4 | 2016 | 599 | 0.170 |
Why?
|
| Down-Regulation | 5 | 2008 | 452 | 0.170 |
Why?
|
| Treatment Outcome | 4 | 2010 | 1586 | 0.160 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2000 | 133 | 0.160 |
Why?
|
| Up-Regulation | 4 | 2008 | 534 | 0.160 |
Why?
|
| Electroporation | 3 | 2006 | 21 | 0.160 |
Why?
|
| Denervation | 3 | 2007 | 27 | 0.150 |
Why?
|
| Repressor Proteins | 1 | 2002 | 267 | 0.150 |
Why?
|
| Genetic Vectors | 3 | 2006 | 165 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 1998 | 8 | 0.150 |
Why?
|
| Carrier Proteins | 3 | 2008 | 318 | 0.150 |
Why?
|
| HIV Wasting Syndrome | 1 | 1998 | 8 | 0.150 |
Why?
|
| MicroRNAs | 2 | 2016 | 501 | 0.150 |
Why?
|
| Plasmids | 3 | 2006 | 247 | 0.150 |
Why?
|
| Transcription Factors | 3 | 2013 | 722 | 0.150 |
Why?
|
| Time Factors | 4 | 2008 | 1848 | 0.150 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 122 | 0.140 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2008 | 49 | 0.140 |
Why?
|
| Glucocorticoids | 3 | 2003 | 92 | 0.140 |
Why?
|
| Adrenal Glands | 1 | 1997 | 17 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 2 | 2013 | 686 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 3 | 2013 | 1804 | 0.130 |
Why?
|
| Molecular Sequence Data | 5 | 2001 | 1559 | 0.130 |
Why?
|
| Vascular Diseases | 2 | 2007 | 33 | 0.130 |
Why?
|
| Ischemia | 1 | 1997 | 45 | 0.130 |
Why?
|
| Urinary Tract | 1 | 1996 | 8 | 0.130 |
Why?
|
| Tobacco Smoke Pollution | 1 | 1997 | 54 | 0.130 |
Why?
|
| Rats, Inbred BN | 5 | 2005 | 21 | 0.130 |
Why?
|
| Reperfusion Injury | 1 | 1997 | 57 | 0.130 |
Why?
|
| Reactive Oxygen Species | 5 | 2007 | 518 | 0.130 |
Why?
|
| Age Factors | 4 | 2007 | 1139 | 0.130 |
Why?
|
| Phenotype | 2 | 2009 | 774 | 0.120 |
Why?
|
| Mice, Inbred C3H | 3 | 2005 | 80 | 0.120 |
Why?
|
| Dihydrotestosterone | 3 | 2003 | 28 | 0.120 |
Why?
|
| Estrogens | 1 | 2016 | 202 | 0.120 |
Why?
|
| Pentoxifylline | 2 | 2006 | 6 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1995 | 85 | 0.110 |
Why?
|
| Metalloproteases | 1 | 2014 | 17 | 0.110 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 228 | 0.110 |
Why?
|
| Testis | 5 | 2005 | 203 | 0.110 |
Why?
|
| Models, Animal | 3 | 2004 | 149 | 0.110 |
Why?
|
| Blotting, Northern | 3 | 2002 | 149 | 0.110 |
Why?
|
| Body Weight | 3 | 2009 | 428 | 0.110 |
Why?
|
| Adipose Tissue | 2 | 2005 | 180 | 0.110 |
Why?
|
| Cell Culture Techniques | 1 | 2014 | 151 | 0.110 |
Why?
|
| Dexamethasone | 3 | 2003 | 55 | 0.100 |
Why?
|
| Mice, Transgenic | 2 | 2007 | 658 | 0.100 |
Why?
|
| Mice, Inbred mdx | 1 | 2013 | 7 | 0.100 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2013 | 11 | 0.100 |
Why?
|
| Dystrophin | 1 | 2013 | 20 | 0.100 |
Why?
|
| HIV-1 | 1 | 1998 | 747 | 0.100 |
Why?
|
| beta-Galactosidase | 2 | 2002 | 37 | 0.100 |
Why?
|
| Adenoviridae | 2 | 2002 | 62 | 0.100 |
Why?
|
| Amino Acid Sequence | 3 | 2000 | 1188 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 174 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2006 | 574 | 0.090 |
Why?
|
| Cell Nucleus | 2 | 2005 | 383 | 0.090 |
Why?
|
| Estradiol | 1 | 2013 | 269 | 0.090 |
Why?
|
| Allopurinol | 1 | 2011 | 13 | 0.090 |
Why?
|
| Nitric Oxide Donors | 1 | 2011 | 41 | 0.090 |
Why?
|
| Gonadotropin-Releasing Hormone | 3 | 2002 | 39 | 0.090 |
Why?
|
| Xanthine Dehydrogenase | 1 | 2010 | 2 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 933 | 0.090 |
Why?
|
| Tissue Distribution | 2 | 2002 | 230 | 0.080 |
Why?
|
| Adult | 10 | 2004 | 13458 | 0.080 |
Why?
|
| Penile Implantation | 1 | 2010 | 1 | 0.080 |
Why?
|
| Oxidoreductases | 2 | 2004 | 79 | 0.080 |
Why?
|
| Transsexualism | 1 | 2010 | 20 | 0.080 |
Why?
|
| CHO Cells | 2 | 2001 | 123 | 0.080 |
Why?
|
| Uterine Prolapse | 1 | 2009 | 3 | 0.080 |
Why?
|
| Muscle Cells | 1 | 2009 | 12 | 0.080 |
Why?
|
| Intestine, Small | 1 | 2009 | 25 | 0.080 |
Why?
|
| Cricetinae | 2 | 2001 | 241 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 98 | 0.080 |
Why?
|
| Triazines | 2 | 2006 | 25 | 0.080 |
Why?
|
| Veins | 1 | 2009 | 7 | 0.080 |
Why?
|
| Cloning, Molecular | 3 | 2001 | 318 | 0.080 |
Why?
|
| Cytokines | 2 | 2004 | 661 | 0.080 |
Why?
|
| Kidney Function Tests | 1 | 2009 | 30 | 0.080 |
Why?
|
| Colchicine | 1 | 2008 | 15 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 729 | 0.070 |
Why?
|
| Tubulin Modulators | 1 | 2008 | 18 | 0.070 |
Why?
|
| Caspase 2 | 1 | 2008 | 7 | 0.070 |
Why?
|
| Insulin | 1 | 2010 | 255 | 0.070 |
Why?
|
| Carcinoma 256, Walker | 1 | 1988 | 1 | 0.070 |
Why?
|
| Random Allocation | 1 | 2008 | 145 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2009 | 131 | 0.070 |
Why?
|
| Smad Proteins | 1 | 2008 | 12 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2008 | 973 | 0.070 |
Why?
|
| DNA, Neoplasm | 1 | 1988 | 92 | 0.070 |
Why?
|
| Follistatin | 1 | 2008 | 28 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 201 | 0.070 |
Why?
|
| Cryptorchidism | 2 | 1997 | 3 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 116 | 0.070 |
Why?
|
| Middle Aged | 5 | 2006 | 11819 | 0.070 |
Why?
|
| Aged | 3 | 2004 | 7982 | 0.070 |
Why?
|
| Video Recording | 1 | 2007 | 40 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1988 | 165 | 0.070 |
Why?
|
| Orchiectomy | 2 | 1997 | 38 | 0.060 |
Why?
|
| NG-Nitroarginine Methyl Ester | 2 | 1997 | 36 | 0.060 |
Why?
|
| Cell Division | 3 | 2003 | 314 | 0.060 |
Why?
|
| Lac Operon | 1 | 2006 | 21 | 0.060 |
Why?
|
| Stroke Volume | 1 | 2007 | 122 | 0.060 |
Why?
|
| Heart Ventricles | 1 | 2007 | 123 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2006 | 148 | 0.060 |
Why?
|
| TCF Transcription Factors | 1 | 2005 | 17 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2005 | 23 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2006 | 154 | 0.060 |
Why?
|
| Antigens, CD34 | 1 | 2005 | 19 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 170 | 0.060 |
Why?
|
| MyoD Protein | 1 | 2005 | 9 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 2005 | 53 | 0.060 |
Why?
|
| Azacitidine | 1 | 2005 | 22 | 0.060 |
Why?
|
| Osteoblasts | 1 | 2005 | 44 | 0.060 |
Why?
|
| Exons | 2 | 1998 | 91 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2009 | 662 | 0.060 |
Why?
|
| Osteogenesis | 1 | 2005 | 57 | 0.060 |
Why?
|
| Papaverine | 1 | 2004 | 2 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 239 | 0.060 |
Why?
|
| beta Catenin | 1 | 2005 | 75 | 0.060 |
Why?
|
| Castration | 1 | 2004 | 34 | 0.060 |
Why?
|
| Androstenedione | 1 | 2004 | 19 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2005 | 104 | 0.060 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2004 | 9 | 0.060 |
Why?
|
| Hypogonadism | 1 | 2004 | 23 | 0.060 |
Why?
|
| Germ Cells | 1 | 2005 | 74 | 0.060 |
Why?
|
| Thymosin | 1 | 2004 | 3 | 0.060 |
Why?
|
| Fascia | 1 | 2004 | 3 | 0.060 |
Why?
|
| Cortactin | 1 | 2004 | 4 | 0.060 |
Why?
|
| Absorptiometry, Photon | 1 | 2004 | 74 | 0.060 |
Why?
|
| DNA Primers | 1 | 2005 | 295 | 0.060 |
Why?
|
| Xanthine Oxidase | 1 | 2004 | 9 | 0.060 |
Why?
|
| Injections | 1 | 2004 | 40 | 0.060 |
Why?
|
| HIV Infections | 1 | 1998 | 2535 | 0.050 |
Why?
|
| Matrix Metalloproteinases | 1 | 2004 | 49 | 0.050 |
Why?
|
| Urologic Surgical Procedures | 1 | 2004 | 5 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2004 | 72 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2003 | 81 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2004 | 84 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 59 | 0.050 |
Why?
|
| Weightlessness Simulation | 2 | 2000 | 26 | 0.050 |
Why?
|
| Human Growth Hormone | 1 | 2003 | 21 | 0.050 |
Why?
|
| Inflammation | 1 | 2009 | 729 | 0.050 |
Why?
|
| Ligands | 2 | 2004 | 387 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2003 | 141 | 0.050 |
Why?
|
| Collagen Type I | 1 | 2002 | 35 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 1996 | 454 | 0.050 |
Why?
|
| Vimentin | 1 | 2002 | 38 | 0.050 |
Why?
|
| Disease Progression | 1 | 2005 | 661 | 0.050 |
Why?
|
| Peroxynitrous Acid | 1 | 2002 | 5 | 0.050 |
Why?
|
| Pancreatic Elastase | 1 | 2002 | 7 | 0.050 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2002 | 10 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 167 | 0.050 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2002 | 7 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 602 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2002 | 31 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 79 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2001 | 50 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2002 | 106 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2002 | 80 | 0.040 |
Why?
|
| Oxytocin | 1 | 2001 | 24 | 0.040 |
Why?
|
| RNA | 1 | 2003 | 266 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 2002 | 95 | 0.040 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2000 | 25 | 0.040 |
Why?
|
| Ubiquitins | 1 | 2000 | 47 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2000 | 69 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 254 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2000 | 64 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2002 | 55 | 0.040 |
Why?
|
| Muscle Contraction | 1 | 2000 | 67 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2000 | 115 | 0.040 |
Why?
|
| Drosophila | 1 | 2001 | 150 | 0.040 |
Why?
|
| Bed Rest | 1 | 1999 | 3 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2000 | 139 | 0.040 |
Why?
|
| Evidence-Based Medicine | 2 | 2010 | 107 | 0.040 |
Why?
|
| Sex Factors | 1 | 2003 | 1008 | 0.040 |
Why?
|
| Triiodothyronine | 1 | 1999 | 36 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2003 | 1516 | 0.040 |
Why?
|
| Introns | 1 | 1998 | 80 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2003 | 1574 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 557 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 1998 | 198 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 1058 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2001 | 461 | 0.030 |
Why?
|
| DNA | 1 | 2001 | 594 | 0.030 |
Why?
|
| Adrenalectomy | 1 | 1997 | 23 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2000 | 429 | 0.030 |
Why?
|
| Citrulline | 1 | 1997 | 14 | 0.030 |
Why?
|
| Pregnatrienes | 1 | 1997 | 1 | 0.030 |
Why?
|
| Cattle | 1 | 1998 | 505 | 0.030 |
Why?
|
| Aldosterone | 1 | 1997 | 66 | 0.030 |
Why?
|
| Cotinine | 1 | 1997 | 44 | 0.030 |
Why?
|
| Seminiferous Tubules | 1 | 1996 | 9 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 1998 | 508 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 1997 | 89 | 0.030 |
Why?
|
| Cholestenone 5 alpha-Reductase | 1 | 1996 | 2 | 0.030 |
Why?
|
| Finasteride | 1 | 1996 | 4 | 0.030 |
Why?
|
| Nicotinic Agonists | 1 | 1997 | 87 | 0.030 |
Why?
|
| Rats, Inbred BB | 1 | 1995 | 3 | 0.030 |
Why?
|
| Drug Implants | 1 | 1995 | 20 | 0.030 |
Why?
|
| Reflex | 1 | 1995 | 29 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 1997 | 102 | 0.030 |
Why?
|
| Cytosol | 1 | 1996 | 98 | 0.030 |
Why?
|
| Pressure | 1 | 1995 | 49 | 0.030 |
Why?
|
| Child | 1 | 2003 | 3381 | 0.030 |
Why?
|
| 3T3 Cells | 2 | 2005 | 61 | 0.030 |
Why?
|
| Adolescent | 2 | 2003 | 5950 | 0.030 |
Why?
|
| Prevalence | 2 | 2010 | 1597 | 0.030 |
Why?
|
| Nicotine | 1 | 1997 | 290 | 0.030 |
Why?
|
| Reference Values | 2 | 2004 | 207 | 0.030 |
Why?
|
| Kinetics | 2 | 2004 | 698 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1991 | 45 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1991 | 132 | 0.020 |
Why?
|
| Penile Prosthesis | 1 | 2010 | 1 | 0.020 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2010 | 2 | 0.020 |
Why?
|
| Amputation, Traumatic | 1 | 2010 | 1 | 0.020 |
Why?
|
| Replantation | 1 | 2010 | 1 | 0.020 |
Why?
|
| Sexology | 1 | 2010 | 2 | 0.020 |
Why?
|
| Rupture | 1 | 2010 | 5 | 0.020 |
Why?
|
| Urology | 1 | 2010 | 9 | 0.020 |
Why?
|
| Wounds, Penetrating | 1 | 2010 | 22 | 0.020 |
Why?
|
| Brain | 1 | 1998 | 1452 | 0.020 |
Why?
|
| Medicine | 1 | 2010 | 37 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 225 | 0.020 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2008 | 16 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2008 | 30 | 0.020 |
Why?
|
| Patient Selection | 1 | 2010 | 192 | 0.020 |
Why?
|
| Aldehydes | 1 | 2008 | 69 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 82 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 1988 | 158 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 152 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 3942 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 158 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2006 | 282 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2004 | 35 | 0.010 |
Why?
|
| Protein Transport | 1 | 2005 | 295 | 0.010 |
Why?
|
| Plasminogen Inactivators | 1 | 2004 | 4 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 42 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 223 | 0.010 |
Why?
|
| Receptors, Somatotropin | 1 | 2003 | 18 | 0.010 |
Why?
|
| Physical Exertion | 1 | 2003 | 27 | 0.010 |
Why?
|
| Tosyl Compounds | 1 | 2003 | 4 | 0.010 |
Why?
|
| Anilides | 1 | 2003 | 28 | 0.010 |
Why?
|
| Arteries | 1 | 2004 | 81 | 0.010 |
Why?
|
| Androgen Antagonists | 1 | 2003 | 29 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 111 | 0.010 |
Why?
|
| Mifepristone | 1 | 2003 | 34 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2003 | 34 | 0.010 |
Why?
|
| Nitriles | 1 | 2003 | 78 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 462 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 382 | 0.010 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2002 | 7 | 0.010 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2002 | 10 | 0.010 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2002 | 10 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2002 | 34 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 2001 | 21 | 0.010 |
Why?
|
| DNA Probes | 1 | 2001 | 33 | 0.010 |
Why?
|
| Pituitary-Adrenal System | 1 | 2002 | 41 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2001 | 63 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2002 | 305 | 0.010 |
Why?
|
| Head-Down Tilt | 1 | 1999 | 4 | 0.010 |
Why?
|
| Thyroxine | 1 | 1999 | 21 | 0.010 |
Why?
|
| Thyrotropin | 1 | 1999 | 23 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2001 | 330 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2003 | 916 | 0.010 |
Why?
|
| United States | 1 | 2010 | 5072 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2002 | 577 | 0.010 |
Why?
|
| Rats, Mutant Strains | 1 | 1996 | 7 | 0.010 |
Why?
|
| Atrophy | 1 | 1996 | 51 | 0.010 |
Why?
|
| Nitrites | 1 | 1993 | 54 | 0.010 |
Why?
|
| Nitrates | 1 | 1993 | 63 | 0.010 |
Why?
|